GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.

Hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) and Golgi protein 73 (GP73) is a serum biomarker for liver diseases and HCC. However, the mechanism underlying GP73 regulates HCV infection is largely unknown. Here, we revealed that GP7...

Full description

Bibliographic Details
Main Authors: Xuewu Zhang, Chengliang Zhu, Tianci Wang, Hui Jiang, Yahui Ren, Qi Zhang, Kailang Wu, Fang Liu, Yingle Liu, Jianguo Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-04-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC5398727?pdf=render
_version_ 1830404755522846720
author Xuewu Zhang
Chengliang Zhu
Tianci Wang
Hui Jiang
Yahui Ren
Qi Zhang
Kailang Wu
Fang Liu
Yingle Liu
Jianguo Wu
author_facet Xuewu Zhang
Chengliang Zhu
Tianci Wang
Hui Jiang
Yahui Ren
Qi Zhang
Kailang Wu
Fang Liu
Yingle Liu
Jianguo Wu
author_sort Xuewu Zhang
collection DOAJ
description Hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) and Golgi protein 73 (GP73) is a serum biomarker for liver diseases and HCC. However, the mechanism underlying GP73 regulates HCV infection is largely unknown. Here, we revealed that GP73 acts as a novel negative regulator of host innate immunity to facilitate HCV infection. GP73 expression is activated and correlated with interferon-beta (IFN-β) production during HCV infection in patients' serum, primary human hepatocytes (PHHs) and human hepatoma cells through mitochondrial antiviral signaling protein (MAVS), TNF receptor-associated factor 6 (TRAF6) and mitogen-activated protein kinase kinase/extracellular regulated protein kinase (MEK/ERK) pathway. Detailed studies revealed that HCV infection activates MAVS that in turn recruits TRAF6 via TRAF-interacting-motifs (TIMs), and TRAF6 subsequently directly recruits GP73 to MAVS via coiled-coil domain. After binding with MAVS and TRAF6, GP73 promotes MAVS and TRAF6 degradation through proteasome-dependent pathway. Moreover, GP73 attenuates IFN-β promoter, IFN-stimulated response element (ISRE) and nuclear factor κB (NF-κB) promoter and down-regulates IFN-β, IFN-λ1, interleukin-6 (IL-6) and IFN-stimulated gene 56 (ISG56), leading to the repression of host innate immunity. Finally, knock-down of GP73 down-regulates HCV infection and replication in Huh7-MAVSR cells and primary human hepatocytes (PHHs), but such repression is rescued by GP73m4 (a mutant GP73 resists to GP73-shRNA#4) in Huh7-MAVSR cells, suggesting that GP73 facilitates HCV infection. Taken together, we demonstrated that GP73 acts as a negative regulator of innate immunity to facilitate HCV infection by interacting with MAVS/TRAF6 and promoting MAVS/TRAF6 degradation. This study provides new insights into the mechanism of HCV infection and pathogenesis, and suggests that GP73 is a new potential antiviral target in the prevention and treatment of HCV associated diseases.
first_indexed 2024-12-20T17:31:48Z
format Article
id doaj.art-b5a640908626463f9dfa1c985b6ade7c
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-20T17:31:48Z
publishDate 2017-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-b5a640908626463f9dfa1c985b6ade7c2022-12-21T19:31:22ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742017-04-01134e100632110.1371/journal.ppat.1006321GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.Xuewu ZhangChengliang ZhuTianci WangHui JiangYahui RenQi ZhangKailang WuFang LiuYingle LiuJianguo WuHepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) and Golgi protein 73 (GP73) is a serum biomarker for liver diseases and HCC. However, the mechanism underlying GP73 regulates HCV infection is largely unknown. Here, we revealed that GP73 acts as a novel negative regulator of host innate immunity to facilitate HCV infection. GP73 expression is activated and correlated with interferon-beta (IFN-β) production during HCV infection in patients' serum, primary human hepatocytes (PHHs) and human hepatoma cells through mitochondrial antiviral signaling protein (MAVS), TNF receptor-associated factor 6 (TRAF6) and mitogen-activated protein kinase kinase/extracellular regulated protein kinase (MEK/ERK) pathway. Detailed studies revealed that HCV infection activates MAVS that in turn recruits TRAF6 via TRAF-interacting-motifs (TIMs), and TRAF6 subsequently directly recruits GP73 to MAVS via coiled-coil domain. After binding with MAVS and TRAF6, GP73 promotes MAVS and TRAF6 degradation through proteasome-dependent pathway. Moreover, GP73 attenuates IFN-β promoter, IFN-stimulated response element (ISRE) and nuclear factor κB (NF-κB) promoter and down-regulates IFN-β, IFN-λ1, interleukin-6 (IL-6) and IFN-stimulated gene 56 (ISG56), leading to the repression of host innate immunity. Finally, knock-down of GP73 down-regulates HCV infection and replication in Huh7-MAVSR cells and primary human hepatocytes (PHHs), but such repression is rescued by GP73m4 (a mutant GP73 resists to GP73-shRNA#4) in Huh7-MAVSR cells, suggesting that GP73 facilitates HCV infection. Taken together, we demonstrated that GP73 acts as a negative regulator of innate immunity to facilitate HCV infection by interacting with MAVS/TRAF6 and promoting MAVS/TRAF6 degradation. This study provides new insights into the mechanism of HCV infection and pathogenesis, and suggests that GP73 is a new potential antiviral target in the prevention and treatment of HCV associated diseases.http://europepmc.org/articles/PMC5398727?pdf=render
spellingShingle Xuewu Zhang
Chengliang Zhu
Tianci Wang
Hui Jiang
Yahui Ren
Qi Zhang
Kailang Wu
Fang Liu
Yingle Liu
Jianguo Wu
GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
PLoS Pathogens
title GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
title_full GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
title_fullStr GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
title_full_unstemmed GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
title_short GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
title_sort gp73 represses host innate immune response to promote virus replication by facilitating mavs and traf6 degradation
url http://europepmc.org/articles/PMC5398727?pdf=render
work_keys_str_mv AT xuewuzhang gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT chengliangzhu gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT tianciwang gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT huijiang gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT yahuiren gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT qizhang gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT kailangwu gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT fangliu gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT yingleliu gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation
AT jianguowu gp73represseshostinnateimmuneresponsetopromotevirusreplicationbyfacilitatingmavsandtraf6degradation